LifeScience Alley, the trade group for Minnesota medtech firms, signed a memorandum of understanding with the FDA's Center for Devices and Radiological Health to develop clearer and faster procedures for the FDA's review of medical devices, according to a Minnesota Public Radio report.
Minnesota has a large contingency of medical device companies. In general, medical device companies say the approval process is slow while FDA critics say the agency's review have not been stringent enough.
"The intent here is about reducing the time and cost to develop, assess and review medical devices, so we can bring important technology to patients more quickly but with robust data to know that in fact they are going to benefit patients," Jeffery Shuren, MD, who oversees the FDA division responsible for medical devices, said.
Related Articles on Medical Devices:
CMS Targets Unnecessary Medical Technology, Devices
Global Medical Device Market Will Reach $350B by 2016
Qualcomm Launches Medical Devices Subsidiary Backed by $100M Fund
Minnesota has a large contingency of medical device companies. In general, medical device companies say the approval process is slow while FDA critics say the agency's review have not been stringent enough.
"The intent here is about reducing the time and cost to develop, assess and review medical devices, so we can bring important technology to patients more quickly but with robust data to know that in fact they are going to benefit patients," Jeffery Shuren, MD, who oversees the FDA division responsible for medical devices, said.
Related Articles on Medical Devices:
CMS Targets Unnecessary Medical Technology, Devices
Global Medical Device Market Will Reach $350B by 2016
Qualcomm Launches Medical Devices Subsidiary Backed by $100M Fund